rgenix.comHealthcareFounded: 2010Funding to Date: $83.5MM
Rgenix is a developer of first-in-class drugs that target key pathways in cancer progression.
For more details on financing and valuation for Rgenix, register or login.
View Enterprise Value for Rgenix.
To read this article and more news on Rgenix, register or login.